Lv7
4920 积分 2021-12-15 加入
LORIS: A multicentre, randomised phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ (DCIS): 5 year follow up. ISRCTN: 27544579. Currently in long term follow up. Sponsor: University Birmingham
4天前
待确认
Active Monitoring for Low-Risk Ductal Carcinoma In Situ
4天前
已完结
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ
4天前
已完结
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial
1个月前
已完结
A multicentre phase 2 study of trifluridine/tipiracil in recurrent/metastatic platinum resistant nasopharyngeal carcinomas
1个月前
已完结
Gut microbiome composition and functional potential associate with incident type 2 diabetes in 4,685 adults from a Swedish prospective cohort
2个月前
已完结
Phased Variant–Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study
2个月前
已完结
Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug‐resistant infections
3个月前
已完结
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study
4个月前
已完结
Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study
4个月前
已完结
皖公网安备34019202002308
